Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JASON C SAYLOR

Allopathic & Osteopathic Physicians Family Medicine

NPI
1407086846
CMS profile
63031
Location
LAKELAND, FL

General Payments · PY2018–2024

$104,875.75

  • Reported across 681 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$21,116.81

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $20,609.03 9
Food and Beverage $507.78 26

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,767.53 217
PY2019 $2,937.77 220
PY2020 $3,148.44 49
PY2021 $28,548.51 50
PY2022 $27,520.60 71
PY2023 $18,836.09 39
PY2024 $21,116.81 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.08 01/11/2024 Food and Beverage Undisputed 01/23/2026 1106027774 CMS
ABBVIE INC. $27.19 01/12/2024 Food and Beverage Undisputed 01/23/2026 1106027776 CMS
ABBVIE INC. $21.02 02/05/2024 Food and Beverage Undisputed 01/23/2026 1106027778 CMS
ABBVIE INC. $21.81 03/21/2024 Food and Beverage Undisputed 01/23/2026 1106027780 CMS
ABBVIE INC. $10.72 04/12/2024 Food and Beverage Undisputed 01/23/2026 1106027782 CMS
ABBVIE INC. $12.90 05/02/2024 Food and Beverage Undisputed 01/23/2026 1106027784 CMS
ABBVIE INC. $21.16 06/20/2024 Food and Beverage Undisputed 01/23/2026 1106027786 CMS
ABBVIE INC. $19.67 07/15/2024 Food and Beverage Undisputed 01/23/2026 1106027788 CMS
ABBVIE INC. $27.28 10/22/2024 Food and Beverage Undisputed 01/23/2026 1106027790 CMS
Amgen Inc. $13.89 08/23/2024 Food and Beverage Undisputed 01/23/2026 1117375259 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.44 01/08/2024 Food and Beverage Undisputed 01/23/2026 1117995648 CMS
Dexcom, Inc. $22.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 1153306921 CMS
GlaxoSmithKline, LLC. $16.42 02/06/2024 Food and Beverage Undisputed 01/23/2026 1115781687 CMS
Lilly USA, LLC $17.24 04/29/2024 Food and Beverage Undisputed 01/23/2026 1135052438 CMS
Novartis Pharmaceuticals Corporation $20.46 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087278429 CMS
Novartis Pharmaceuticals Corporation $19.76 04/01/2024 Food and Beverage Undisputed 01/23/2026 1087278435 CMS
Novo Nordisk Inc $16.50 02/12/2024 Food and Beverage Undisputed 01/23/2026 1097169747 CMS
Novo Nordisk Inc $16.29 03/18/2024 Food and Beverage Undisputed 01/23/2026 1096902107 CMS
Phathom Pharmaceuticals, Inc. $19.96 05/21/2024 Food and Beverage Undisputed 01/23/2026 1151121206 CMS
Phathom Pharmaceuticals, Inc. $24.76 08/12/2024 Food and Beverage Undisputed 01/23/2026 1151121208 CMS
Phathom Pharmaceuticals, Inc. $24.66 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151121210 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.62 09/04/2024 Food and Beverage Undisputed 01/23/2026 1153709418 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.81 10/04/2024 Food and Beverage Undisputed 01/23/2026 1153468091 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.88 12/16/2024 Food and Beverage Undisputed 01/23/2026 1153760745 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137669082 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137669084 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137669086 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137669088 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137669090 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137669092 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,267.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137669094 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,367.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137669096 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,367.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137669098 CMS
Tris Pharma Inc $18.41 10/15/2024 Food and Beverage Undisputed 01/23/2026 1147224492 CMS
Tris Pharma Inc $18.68 11/19/2024 Food and Beverage Undisputed 01/23/2026 1147224494 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.